Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 "Lithium in Brain" Study Taking Place at Massachusetts General Hospital

Stock Information for Alzamend Neuro Inc.

Loading

Please wait while we load your information from QuoteMedia.